James Michael O'brien - Net Worth and Insider Trading
James Michael O'brien Net Worth
The estimated net worth of James Michael O'brien is at least $35,689 dollars as of 2024-11-13. James Michael O'brien is the EVP of Finance of Enzo Biochem Inc and owns about 28,187 shares of Enzo Biochem Inc (ENZ) stock worth over $32,697. James Michael O'brien is also the CFO of Cognition Therapeutics Inc and owns about 5,000 shares of Cognition Therapeutics Inc (CGTX) stock worth over $2,992. Details can be seen in James Michael O'brien's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Michael O'brien has not made any transactions after 2021-10-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Michael O'brien
James Michael O'brien Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Michael O'brien owns 2 companies in total, including Enzo Biochem Inc (ENZ) , and Cognition Therapeutics Inc (CGTX) .
Click here to see the complete history of James Michael O'brien’s form 4 insider trades.
Insider Ownership Summary of James Michael O'brien
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENZ | Enzo Biochem Inc | 2017-10-27 | SVP of Finance |
| CGTX | Cognition Therapeutics Inc | 2022-03-23 | Chief Financial Officer |
James Michael O'brien Latest Holdings Summary
James Michael O'brien currently owns a total of 2 stocks. Among these stocks, James Michael O'brien owns 28,187 shares of Enzo Biochem Inc (ENZ) as of October 27, 2017, with a value of $32,697 and a weighting of 91.62%. James Michael O'brien also owns 5,000 shares of Cognition Therapeutics Inc (CGTX) as of October 13, 2021, with a value of $2,992 and a weighting of 8.38%.
Latest Holdings of James Michael O'brien
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENZ | Enzo Biochem Inc | 2017-10-27 | 28,187 | 1.16 | 32,697 |
| CGTX | Cognition Therapeutics Inc | 2021-10-13 | 5,000 | 0.60 | 2,992 |
Holding Weightings of James Michael O'brien
James Michael O'brien Form 4 Trading Tracker
According to the SEC Form 4 filings, James Michael O'brien has made a total of 0 transactions in Enzo Biochem Inc (ENZ) over the past 5 years. The most-recent trade in Enzo Biochem Inc is the sale of 22,866 shares on October 27, 2017, which brought James Michael O'brien around $235,062.
According to the SEC Form 4 filings, James Michael O'brien has made a total of 1 transactions in Cognition Therapeutics Inc (CGTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cognition Therapeutics Inc is the acquisition of 5,000 shares on October 13, 2021, which cost James Michael O'brien around $60,000.
Insider Trading History of James Michael O'brien
- 1
James Michael O'brien Trading Performance
GuruFocus tracks the stock performance after each of James Michael O'brien's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Michael O'brien is -46.97%. GuruFocus also compares James Michael O'brien's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Michael O'brien within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Michael O'brien's insider trading performs compared to the benchmark.
Performance of James Michael O'brien
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.77 | | | | | |
| Relative Return to S&P 500(%) | -11.08 | | | | | |
James Michael O'brien Ownership Network
Ownership Network List of James Michael O'brien
Ownership Network Relation of James Michael O'brien
James Michael O'brien Owned Company Details
What does Enzo Biochem Inc do?
Who are the key executives at Enzo Biochem Inc?
James Michael O'brien is the SVP of Finance of Enzo Biochem Inc. Other key executives at Enzo Biochem Inc include 10 percent owner James G. Wolf , Chief Executive Officer Hamid Erfanian , and Interim CFO Patricia Eckert .
Enzo Biochem Inc (ENZ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Enzo Biochem Inc (ENZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Enzo Biochem Inc (ENZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Enzo Biochem Inc (ENZ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enzo Biochem Inc Insider Transactions
James Michael O'brien Mailing Address
Above is the net worth, insider trading, and ownership report for James Michael O'brien. You might contact James Michael O'brien via mailing address: C/o Enzo Biochem Inc., 527 Madison Ave., New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
